GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Takara Bio Inc (TSE:4974) » Definitions » E10

Takara Bio (TSE:4974) E10 : 円53.27 (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Takara Bio E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Takara Bio's adjusted earnings per share data for the three months ended in Mar. 2024 was 円11.012. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is 円53.27 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Takara Bio's average E10 Growth Rate was 2.40% per year. During the past 3 years, the average E10 Growth Rate was 32.70% per year. During the past 5 years, the average E10 Growth Rate was 38.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Takara Bio was 49.80% per year. The lowest was 27.30% per year. And the median was 38.70% per year.

As of today (2024-06-04), Takara Bio's current stock price is 円1030.00. Takara Bio's E10 for the quarter that ended in Mar. 2024 was 円53.27. Takara Bio's Shiller PE Ratio of today is 19.34.

During the past 13 years, the highest Shiller PE Ratio of Takara Bio was 279.01. The lowest was 17.95. And the median was 131.58.


Takara Bio E10 Historical Data

The historical data trend for Takara Bio's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takara Bio E10 Chart

Takara Bio Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.48 22.80 38.74 52.02 53.27

Takara Bio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.02 52.93 53.61 52.85 53.27

Competitive Comparison of Takara Bio's E10

For the Biotechnology subindustry, Takara Bio's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Takara Bio's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Takara Bio's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Takara Bio's Shiller PE Ratio falls into.



Takara Bio E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Takara Bio's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=11.012/107.2000*107.2000
=11.012

Current CPI (Mar. 2024) = 107.2000.

Takara Bio Quarterly Data

per share eps CPI Adj_EPS
201406 0.150 98.000 0.164
201409 3.200 98.500 3.483
201412 -4.060 97.900 -4.446
201503 8.695 97.900 9.521
201506 -0.300 98.400 -0.327
201509 1.503 98.500 1.636
201512 3.887 98.100 4.248
201603 5.980 97.900 6.548
201606 2.370 98.100 2.590
201609 3.170 98.000 3.468
201612 7.424 98.400 8.088
201703 -1.736 98.100 -1.897
201706 0.190 98.500 0.207
201709 2.320 98.800 2.517
201712 6.361 99.400 6.860
201803 10.510 99.200 11.358
201806 8.570 99.200 9.261
201809 5.714 99.900 6.132
201812 3.056 99.700 3.286
201903 13.030 99.700 14.010
201906 13.220 99.800 14.200
201909 4.010 100.100 4.294
201912 5.257 100.500 5.607
202003 9.226 100.300 9.861
202006 3.360 99.900 3.606
202009 15.530 99.900 16.665
202012 28.667 99.300 30.948
202103 31.730 99.900 34.049
202106 50.040 99.500 53.912
202109 33.080 100.100 35.426
202112 36.166 100.100 38.731
202203 45.550 101.100 48.298
202206 32.450 101.800 34.171
202209 38.459 103.100 39.988
202212 50.300 104.100 51.798
202303 11.760 104.400 12.075
202306 2.650 105.200 2.700
202309 6.350 106.200 6.410
202312 -7.723 106.800 -7.752
202403 11.012 107.200 11.012

Add all the adjusted EPS together and divide 10 will get our e10.


Takara Bio  (TSE:4974) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Takara Bio's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=1030.00/53.27
=19.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Takara Bio was 279.01. The lowest was 17.95. And the median was 131.58.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Takara Bio E10 Related Terms

Thank you for viewing the detailed overview of Takara Bio's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Takara Bio (TSE:4974) Business Description

Traded in Other Exchanges
Address
Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, JPN, 520-0058
Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.

Takara Bio (TSE:4974) Headlines

No Headlines